These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 29438119)

  • 41. Liver disease in cystic fibrosis.
    Colombo C; Russo MC; Zazzeron L; Romano G
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S49-55. PubMed ID: 16819402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis.
    Smith JL; Lewindon PJ; Hoskins AC; Pereira TN; Setchell KD; O'Connell NC; Shepherd RW; Ramm GA
    Hepatology; 2004 Jun; 39(6):1673-82. PubMed ID: 15185309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease.
    Rath T; Hage L; Kügler M; Menendez Menendez K; Zachoval R; Naehrlich L; Schulz R; Roderfeld M; Roeb E
    PLoS One; 2013; 8(3):e58955. PubMed ID: 23516586
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extended Screening for Cystic Fibrosis-related Liver Disease Including Elastography in Children and Adolescents.
    Højte C; Jørgensen MH; Jensen F; Katzenstein TL; Skov M
    J Pediatr Gastroenterol Nutr; 2020 Nov; 71(5):663-668. PubMed ID: 33093375
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of liver disease on mortality in cystic fibrosis-A systematic review.
    Sasame A; Stokes D; Bourke B; Connolly L; Fitzpatrick E; Rowland M
    J Cyst Fibros; 2022 Mar; 21(2):202-211. PubMed ID: 34380590
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cystic Fibrosis-related Liver Disease: The Next Challenge.
    Baker RD; Baker SS
    J Pediatr Gastroenterol Nutr; 2020 Oct; 71(4):421-422. PubMed ID: 32740535
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liver disease in cystic fibrosis.
    Colombo C
    Curr Opin Pulm Med; 2007 Nov; 13(6):529-36. PubMed ID: 17901760
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Liver disease in cystic fibrosis.
    Leeuwen L; Fitzgerald DA; Gaskin KJ
    Paediatr Respir Rev; 2014 Mar; 15(1):69-74. PubMed ID: 23769887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA Sequencing Identifies a Serum MicroRNA Panel, Which Combined With Aspartate Aminotransferase to Platelet Ratio Index Can Detect and Monitor Liver Disease in Pediatric Cystic Fibrosis.
    Calvopina DA; Chatfield MD; Weis A; Coleman MA; Fernandez-Rojo MA; Noble C; Ramm LE; Leung DH; Lewindon PJ; Ramm GA
    Hepatology; 2018 Dec; 68(6):2301-2316. PubMed ID: 30014495
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcomes of patients with cystic fibrosis undergoing lung transplantation with and without cystic fibrosis-associated liver cirrhosis.
    Nash EF; Volling C; Gutierrez CA; Tullis E; Coonar A; McRae K; Keshavjee S; Singer LG; Durie PR; Chaparro C
    Clin Transplant; 2012; 26(1):34-41. PubMed ID: 21272072
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SERPINA1 Z allele is associated with cystic fibrosis liver disease.
    Boëlle PY; Debray D; Guillot L; Corvol H;
    Genet Med; 2019 Sep; 21(9):2151-2155. PubMed ID: 30739910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liver and biliary problems in cystic fibrosis.
    Colombo C; Battezzati PM; Strazzabosco M; Podda M
    Semin Liver Dis; 1998; 18(3):227-35. PubMed ID: 9773423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cystic fibrosis liver disease - from diagnosis to risk factors.
    Ciucă IM; Pop L; Tămaş L; Tăban S
    Rom J Morphol Embryol; 2014; 55(1):91-5. PubMed ID: 24715171
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cystic Fibrosis Liver Disease: Outcomes and Risk Factors in a Large Cohort of French Patients.
    Boëlle PY; Debray D; Guillot L; Clement A; Corvol H;
    Hepatology; 2019 Apr; 69(4):1648-1656. PubMed ID: 30058245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liver involvement in cystic fibrosis.
    Colombo C; Crosignani A; Battezzati PM
    J Hepatol; 1999 Nov; 31(5):946-54. PubMed ID: 10580595
    [No Abstract]   [Full Text] [Related]  

  • 56. Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease.
    Leung DH; Khan M; Minard CG; Guffey D; Ramm LE; Clouston AD; Miller G; Lewindon PJ; Shepherd RW; Ramm GA
    Hepatology; 2015 Nov; 62(5):1576-83. PubMed ID: 26223427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of noninvasive markers for the diagnosis of cystic fibrosis liver disease.
    Alexopoulou A; Pouriki S; Vasilieva L; Alexopoulos T; Filaditaki V; Gioka M; Diamantea F; Dourakis SP
    Scand J Gastroenterol; 2018 Dec; 53(12):1547-1552. PubMed ID: 30600723
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liver disease in cystic fibrosis.
    Rowland M; Bourke B
    Curr Opin Pulm Med; 2011 Nov; 17(6):461-6. PubMed ID: 21881510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modifier genes in cystic fibrosis-related liver disease.
    Debray D; Corvol H; Housset C
    Curr Opin Gastroenterol; 2019 Mar; 35(2):88-92. PubMed ID: 30585791
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatobiliary disease in patients with cystic fibrosis.
    Moyer K; Balistreri W
    Curr Opin Gastroenterol; 2009 May; 25(3):272-8. PubMed ID: 19381084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.